173 related articles for article (PubMed ID: 9657513)
1. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.
Hatz C; Abdulla S; Mull R; Schellenberg D; Gathmann I; Kibatala P; Beck HP; Tanner M; Royce C
Trop Med Int Health; 1998 Jun; 3(6):498-504. PubMed ID: 9657513
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India.
Kshirsagar NA; Gogtay NJ; Moorthy NS; Garg MR; Dalvi SS; Chogle AR; Sorabjee JS; Marathe SN; Tilve GH; Bhatt AD; Sane SP; Mull R; Gathmann I
Am J Trop Med Hyg; 2000 Mar; 62(3):402-8. PubMed ID: 11037786
[TBL] [Abstract][Full Text] [Related]
3. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697.
von Seidlein L; Jaffar S; Pinder M; Haywood M; Snounou G; Gemperli B; Gathmann I; Royce C; Greenwood B
J Infect Dis; 1997 Oct; 176(4):1113-6. PubMed ID: 9333180
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria.
Vugt MV; Wilairatana P; Gemperli B; Gathmann I; Phaipun L; Brockman A; Luxemburger C; White NJ; Nosten F; Looareesuwan S
Am J Trop Med Hyg; 1999 Jun; 60(6):936-42. PubMed ID: 10403324
[TBL] [Abstract][Full Text] [Related]
5. Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children.
Irion A; Felger I; Abdulla S; Smith T; Mull R; Tanner M; Hatz C; Beck HP
Trop Med Int Health; 1998 Jun; 3(6):490-7. PubMed ID: 9657512
[TBL] [Abstract][Full Text] [Related]
6. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand.
Looareesuwan S; Wilairatana P; Chokejindachai W; Chalermrut K; Wernsdorfer W; Gemperli B; Gathmann I; Royce C
Am J Trop Med Hyg; 1999 Feb; 60(2):238-43. PubMed ID: 10072142
[TBL] [Abstract][Full Text] [Related]
9. An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug.
Bakshi R; Hermeling-Fritz I; Gathmann I; Alteri E
Trans R Soc Trop Med Hyg; 2000; 94(4):419-24. PubMed ID: 11127248
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A
Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624
[TBL] [Abstract][Full Text] [Related]
11. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
van Vugt M; Looareesuwan S; Wilairatana P; McGready R; Villegas L; Gathmann I; Mull R; Brockman A; White NJ; Nosten F
Trans R Soc Trop Med Hyg; 2000; 94(5):545-8. PubMed ID: 11132386
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria.
Jiao X; Liu GY; Shan CO; Zhao X; Li XW; Gathmann I; Royce C
Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):476-81. PubMed ID: 9561595
[TBL] [Abstract][Full Text] [Related]
13. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor W; Checchi F; Guthmann JP
Lancet; 2005 Apr 23-29; 365(9469):1467-73. PubMed ID: 15850630
[TBL] [Abstract][Full Text] [Related]
14. The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France.
van Agtmael M; Bouchaud O; Malvy D; Delmont J; Danis M; Barette S; Gras C; Bernard J; Touze JE; Gathmann I; Mull R
Int J Antimicrob Agents; 1999 Jul; 12(2):159-69. PubMed ID: 10418762
[TBL] [Abstract][Full Text] [Related]
15. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
[TBL] [Abstract][Full Text] [Related]
16. Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
Ursing J; Kofoed PE; Rodrigues A; Blessborn D; Thoft-Nielsen R; Björkman A; Rombo L
J Infect Dis; 2011 Jan; 203(1):109-16. PubMed ID: 21148503
[TBL] [Abstract][Full Text] [Related]
17. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
Wernsdorfer WH
Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
[TBL] [Abstract][Full Text] [Related]
18. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.
van Vugt M; Brockman A; Gemperli B; Luxemburger C; Gathmann I; Royce C; Slight T; Looareesuwan S; White NJ; Nosten F
Antimicrob Agents Chemother; 1998 Jan; 42(1):135-9. PubMed ID: 9449273
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria.
Falade C; Makanga M; Premji Z; Ortmann CE; Stockmeyer M; de Palacios PI
Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):459-67. PubMed ID: 15837358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
